Company Overview of Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc., a biotechnology company, develops adjuvants, adjuvanted vaccines, and immunotherapeutics for infectious diseases and cancer in the fields of human health and animal health. Its product JVRS100 is developed as an adjuvant to improve the effectiveness of available vaccines and to develop novel vaccines against otherwise untreatable diseases; and developed as an immunotherapeutic to treat infectious disease and cancer. The company was incorporated in 2001 and is headquartered in Pleasanton, California.
6200 Stoneridge Mall Road
Pleasanton, CA 94588
Founded in 2001
Key Executives for Juvaris BioTherapeutics, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Juvaris BioTherapeutics, Inc., please visit www.juvaris.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.